Skip to Content

Edwards Lifesciences Corp EW

Morningstar Rating
$87.24 −2.81 (3.12%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

EW is trading at a 1% premium.
Price
$87.24
Fair Value
$79.00
Uncertainty
High
1-Star Price
$735.40
5-Star Price
$85.20
Economic Moat
Bmytzz
Capital Allocation
Mvznwxxgs

Bulls Say, Bears Say

Bulls

Edwards' efforts to focus on efficiency and higher-margin products have paid off, as gross margins increased from 47% in 2000 to 77% in 2023.

Bears

Edwards' ambitions to diversify into minimally invasive medical technologies place the firm in direct competition with much larger competitors, such as Medtronic and Abbott, which can easily bid up prices for emerging technologies that Edwards couldn't match.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EW is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$90.05
Day Range
$86.4589.89
52-Week Range
$60.5796.12
Bid/Ask
$86.00 / $87.24
Market Cap
$52.51 Bil
Volume/Avg
2.9 Mil / 3.9 Mil

Key Statistics

Price/Earnings (Normalized)
35.88
Price/Sales
9.14
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.68%

Company Profile

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Growth
Total Number of Employees
19,800

Competitors

Valuation

Metric
EW
MDT
ABT
Price/Earnings (Normalized)
35.8814.6524.60
Price/Book Value
8.142.034.91
Price/Sales
9.143.274.76
Price/Cash Flow
38.5914.4319.62
Price/Earnings
EW
MDT
ABT

Financial Strength

Metric
EW
MDT
ABT
Quick Ratio
2.081.461.16
Current Ratio
3.382.301.64
Interest Coverage
87.988.8610.86
Quick Ratio
EW
MDT
ABT

Profitability

Metric
EW
MDT
ABT
Return on Assets (Normalized)
17.13%7.75%10.63%
Return on Equity (Normalized)
24.32%13.75%20.87%
Return on Invested Capital (Normalized)
21.12%9.87%14.81%
Return on Assets
EW
MDT
ABT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesLzhpzjllDyqcmpm$183.8 Bil
SYK
Stryker CorpSxgfhrblrSfk$127.8 Bil
MDT
Medtronic PLCKnzcvwbnyXrmcnx$105.0 Bil
BSX
Boston Scientific CorpHkbmbccBnmtmch$99.9 Bil
DXCM
DexCom IncBmqvcbtbhtJdh$51.9 Bil
ZBH
Zimmer Biomet Holdings IncBvxcjsbmBps$24.9 Bil
ALGN
Align Technology IncVffjlpvdXldgbk$22.6 Bil
PHG
Koninklijke Philips NV ADRRxptgwypStsxgt$18.2 Bil
PODD
Insulet CorpPvnlynpyjTncnqc$11.6 Bil

Sponsor Center